MURSHID A AL-AWADY

Allopathic & Osteopathic Physicians|Family Medicine MIDDLEBURG, FL NPI 1992719702

General Payments — all program years on this page

$1,093.31

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 61
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $441.25 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $441.2522

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $108.508
2019 $209.6713
2020 $87.116
2021 $42.452
2022 $128.746
2023 $75.594
2024 $441.2522

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086234725 Bayer Healthcare Pharmaceuticals Inc. $20.23 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096999837 Novo Nordisk Inc $22.45 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097724477 Novo Nordisk Inc $21.13 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097784071 Novo Nordisk Inc $16.82 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101341539 E.R. Squibb & Sons, L.L.C. $13.90 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104401821 AstraZeneca Pharmaceuticals LP $17.94 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104653285 AstraZeneca Pharmaceuticals LP $14.10 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104763630 AstraZeneca Pharmaceuticals LP $13.92 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105217198 AstraZeneca Pharmaceuticals LP $15.75 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105354387 AstraZeneca Pharmaceuticals LP $13.12 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105400120 AstraZeneca Pharmaceuticals LP $96.75 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105574210 AstraZeneca Pharmaceuticals LP $13.92 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105727445 AstraZeneca Pharmaceuticals LP $16.36 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105827227 AstraZeneca Pharmaceuticals LP $13.73 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116312572 GlaxoSmithKline, LLC. $15.72 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116416996 GlaxoSmithKline, LLC. $15.36 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116450355 GlaxoSmithKline, LLC. $13.64 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116642186 GlaxoSmithKline, LLC. $19.78 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116727510 GlaxoSmithKline, LLC. $16.40 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117491278 Amgen Inc. $16.00 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117491280 Amgen Inc. $19.99 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137554634 Almatica Pharma LLC $14.24 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.